Expedite Research & Development for Unmet Biomedical Needs

Insilico Biosystems has experienced Computational Biology, Data Sciences, AI/ML and IT professionals previously worked on biotechnology and drug discovery (R&D) in biotech and pharma companies, with proven records across disease areas (oncology, immunology, neurosciences, cardiovascular & metabolism, infectious diseases & vaccine, and regenerative medicine), therapeutic modalities (SM, antibody, ADC, RNA, PROTAC, cell and gene therapies) and portfolio stages (from pre-portfolio to post-market).

Insilico Biosystems analyzes individual project data in combination with those from public and other sources, which increases its power detecting true signals and generating actionable interpretation, therefore delivers more impact to R&D decision-making.